Primary |
Blood Pressure High |
50.0% |
Diabetes Mellitus |
50.0% |
|
Blood Sodium Decreased |
33.3% |
Non-hodgkin's Lymphoma |
33.3% |
Vomiting |
33.3% |
|
Secondary |
Product Used For Unknown Indication |
40.0% |
Age-related Macular Degeneration |
20.0% |
Carcinoid Tumour |
20.0% |
Hypertension |
20.0% |
|
Hyperkalaemia |
50.0% |
Urinary Tract Infection |
50.0% |
|
Concomitant |
Product Used For Unknown Indication |
59.6% |
Hypertension |
6.6% |
Rheumatoid Arthritis |
5.8% |
Blood Pressure |
2.6% |
Gastrooesophageal Reflux Disease |
2.5% |
Hepatitis C |
2.4% |
Crohn's Disease |
2.1% |
Vitamin Supplementation |
2.1% |
Psoriasis |
2.0% |
Asthma |
1.8% |
Blood Cholesterol |
1.8% |
Hypothyroidism |
1.8% |
Pain |
1.7% |
Osteoporosis |
1.3% |
Blood Cholesterol Increased |
1.2% |
Mineral Supplementation |
1.1% |
Atrial Fibrillation |
1.0% |
Diabetes Mellitus |
1.0% |
Depression |
0.9% |
Hypersensitivity |
0.9% |
|
Weight Increased |
9.7% |
Injection Site Pain |
8.3% |
Muscle Spasms |
8.3% |
Nausea |
6.9% |
Vomiting |
6.9% |
Wrong Technique In Drug Usage Process |
5.6% |
Fatigue |
4.2% |
Pain |
4.2% |
Pain In Extremity |
4.2% |
Paraesthesia |
4.2% |
Psoriasis |
4.2% |
Rash |
4.2% |
Sinusitis |
4.2% |
Tremor |
4.2% |
Urinary Tract Infection |
4.2% |
Vitamin D Decreased |
4.2% |
Weight Decreased |
4.2% |
Abdominal Discomfort |
2.8% |
Anaemia |
2.8% |
Drug Ineffective |
2.8% |
|